Ztech aerosol dispensers for liquid and powder personal care products
Zeteo Biomedical's ZTech aerosol dispensers provide advanced, propellant-free delivery for personal care products. Designed for both liquid and powder forms, these dispensers offer silent, precise aerosolization with non-pressurized packaging, meeting pharmaceutical standards.
Overview
Zeteo Biomedical's ZTech aerosol dispensers are innovative solutions for the personal care industry, offering advanced, propellant-free delivery systems for both liquid and powder products. Originally engineered for self-administered drug/device combinations, the ZTech-L (liquid) and ZTech-P (powder) platforms are now optimized for personal care applications. These dispensers are designed to meet rigorous pharmaceutical standards, ensuring precision, safety, and consumer convenience.
Technical specifications
The ZTech platforms include:
- Primary container and aerosolization nozzles: Ensures precise delivery and aerosolization for both liquid and powder forms.
- Dispenser devices: Silent, propellant-free, utilizing mechanical and pneumatic energy systems.
- Blister packaging technology: Non-pressurized, "unit of use" packaging with USP Class VI cold form laminate, providing exceptional barrier properties to protect product content.
- Technical Services: Custom configuration, prototype manufacturing, analytical testing, and consumer focus group testing.
Technology readiness level
The ZTech aerosol dispensers have reached Technology Readiness Level 6. Prototypes have been developed, and preliminary testing has been conducted, including analytical dispense characterization and plume morphology. Future steps include consumer focus group evaluations and further compatibility testing with personal care formulations.
About Zeteo Biomedical LLC
Zeteo Biomedical LLC develops and commercializes advanced, patient-centric drug and biologic delivery systems, specializing in needle-free technology for pharmaceutical, biotech, and personal care applications. The company’s core offerings, the ZTECH-L and ZTECH-P platforms, support the administration of liquid, powder, and reconstituted formulations via ophthalmic, intranasal, nose-to-brain, and sublingual routes. These devices are designed for precision dosing, portability, and ease of use, featuring innovations that allow for reliable functionality in various physical orientations, including microgravity environments. The company complements its proprietary hardware with a suite of technical services, including device prototyping, analytical testing, process engineering, and support for clinical and commercial supply chain management.
By focusing on compact and intuitive design, Zeteo helps its partners improve patient adherence and medical outcomes for conditions ranging from neurodegenerative disorders and pain management to infectious diseases. The company plays a significant role in public health initiatives, having joined the Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) consortium to expedite the distribution of vaccines and biomedical countermeasures. With a robust international patent portfolio, Zeteo provides end-to-end support for drug-device combination products, aiming to maximize treatment efficacy while minimizing drug waste and environmental impact. Their services assist partners from early-stage development through to commercial-scale production and technology licensing.
delivered to your inbox.